CancerCare (@cancercare) 's Twitter Profile
CancerCare

@cancercare

CancerCare is a leading national organization dedicated to providing free support services and financial assistance to anyone affected by cancer. 800-813-HOPE

ID: 32132651

linkhttp://www.cancercare.org/ calendar_today16-04-2009 20:04:20

7,7K Tweet

21,21K Followers

1,1K Following

CancerCare (@cancercare) 's Twitter Profile Photo

CancerCare, in collaboration with St. Joseph’s University Medical Center, hosted two free wig clinics in March and August as part of the Community Outreach Wig Program. Read more: loom.ly/IF1Fc1A

CancerCare, in collaboration with St. Joseph’s University Medical Center, hosted two free wig clinics in March and August as part of the Community Outreach Wig Program.

Read more: loom.ly/IF1Fc1A
CancerCare (@cancercare) 's Twitter Profile Photo

If you or a loved one has been diagnosed with liver cancer, CancerCare is here for you every step of the way with free emotional and practical support and resources. Learn more: cancercare.org/liver_cancer #LiverCancerAwarenessMonth

If you or a loved one has been diagnosed with liver cancer, <a href="/CancerCare/">CancerCare</a> is here for you every step of the way with free emotional and practical support and resources.

Learn more: cancercare.org/liver_cancer

#LiverCancerAwarenessMonth
CancerCare (@cancercare) 's Twitter Profile Photo

CancerCare has free services and resources for people coping with the unique challenges of a metastatic breast cancer diagnosis, including support groups, workshops and publications. Learn more: loom.ly/ueLtD5s

CancerCare has free services and resources for people coping with the unique challenges of a metastatic breast cancer diagnosis, including support groups, workshops and publications.

Learn more: loom.ly/ueLtD5s
GvHD Hub (@gvhd_hub) 's Twitter Profile Photo

Join us on October 21 at 17:00 (BST) for our free healthcare professional virtual symposium. Guidance vs practice: How can we improve treatment of SR-GvHD? Chaired by Mohamad Mohty, with guest speakers Daniel Wolff and Steven Pavletic. Register here ⬇️

Join us on October 21 at 17:00 (BST) for our free healthcare professional virtual symposium. 

Guidance vs practice: How can we improve treatment of SR-GvHD?  

Chaired by Mohamad Mohty, with guest speakers Daniel Wolff and Steven Pavletic. 

Register here ⬇️
CancerCare (@cancercare) 's Twitter Profile Photo

Last week, at Catholic Health, we had the privilege of hosting a free wig clinic. Patients were able to explore beautiful wigs and learn about our programs. It's always a joy to see the smiles as they leave feeling beautiful and confident with their new looks!

Last week, at <a href="/CHS_LI/">Catholic Health</a>, we had the privilege of hosting a free wig clinic. Patients were able to explore beautiful wigs and learn about our programs. It's always a joy to see the smiles as they leave feeling beautiful and confident with their new looks!
CancerCare (@cancercare) 's Twitter Profile Photo

In partnership with Research To Practice, join us for a special webinar for patients next Wednesday, Oct 22, about CAR T-cell therapy for non-lymphoma. Research To Practice #cartcelltherapy #nonHodgkinlymphoma Register here: researchtopractice.com/Webinars/2025C…

In partnership with Research To Practice, join us for a special webinar for patients next Wednesday, Oct 22, about CAR T-cell therapy for non-lymphoma. <a href="/DrNeilLove/">Research To Practice</a>

#cartcelltherapy #nonHodgkinlymphoma 

Register here: researchtopractice.com/Webinars/2025C…
Research To Practice (@drneillove) 's Twitter Profile Photo

Next week, October 22nd, in collaboration with the CancerCare, Dr Neil Love will explore questions that patients ask about CAR T-cell therapy for non-Hodgkin lymphoma. Register at the link. ow.ly/Jgc150X9JzK

Next week, October 22nd, in collaboration with the <a href="/CancerCare/">CancerCare</a>, Dr Neil Love will explore questions that patients ask about CAR T-cell therapy for non-Hodgkin lymphoma. 

Register at the link. ow.ly/Jgc150X9JzK
GvHD Hub (@gvhd_hub) 's Twitter Profile Photo

Don’t forget to join our free healthcare professional virtual symposium on October 21 at 17:00 (BST) to hear experts discussing quality of life in GvHD. Chaired by Mohamad Mohty. Register here ⬇️ loom.ly/tCoLBCc If you’ve missed our virtual symposium and would

Don’t forget to join our free healthcare professional virtual symposium on October 21 at 17:00 (BST) to hear experts discussing quality of life in GvHD. 

Chaired by Mohamad Mohty. 

Register here ⬇️  
loom.ly/tCoLBCc 

If you’ve missed our virtual symposium and would
NCCS - National Coalition for Cancer Survivorship (@canceradvocacy) 's Twitter Profile Photo

Cancer Nation is pleased to partner with @CancerandCareer for their virtual West Coast Conference on Work & Cancer, on Saturday, October 25th! This FREE conference will explore the complexities working people face as they try to balance their cancer treatment and recovery with

Cancer Nation is pleased to partner with @CancerandCareer for their virtual West Coast Conference on Work &amp; Cancer, on Saturday, October 25th! 

This FREE conference will explore the complexities working people face as they try to balance their cancer treatment and recovery with
GvHD Hub (@gvhd_hub) 's Twitter Profile Photo

Don’t miss out on our free healthcare professional virtual symposium on October 21 at 17:00 (BST). Chaired by Mohamad Mohty. Join us live at 17:00 (BST) ⬇️ loom.ly/tCoLBCc Learn more about the importance of real-world data, with a chance for Q&A. #GvHD If

Don’t miss out on our free healthcare professional virtual symposium on October 21 at 17:00 (BST). 

Chaired by Mohamad Mohty. 

Join us live at 17:00 (BST) ⬇️ 
loom.ly/tCoLBCc 

Learn more about the importance of real-world data, with a chance for Q&amp;A. 

#GvHD 

If
Research To Practice (@drneillove) 's Twitter Profile Photo

This Wednesday, in collaboration with the CancerCare, Dr Neil Love will explore questions that patients ask about CAR T-cell therapy for non-Hodgkin lymphoma. Register at the link. ow.ly/fLBc50XczfC

This Wednesday, in collaboration with the <a href="/CancerCare/">CancerCare</a>, Dr Neil Love will explore questions that patients ask about CAR T-cell therapy for non-Hodgkin lymphoma. 

Register at the link. ow.ly/fLBc50XczfC
CancerCare (@cancercare) 's Twitter Profile Photo

We are deeply thankful to Veronica for sharing her journey. By connecting with CancerCare’s services, including a spirituality support group, she discovered relief and empowerment. #cancercare #breastcancer #support #shareherjourney #empowerment #testimonial

We are deeply thankful to Veronica for sharing her journey. By connecting with CancerCare’s services, including a spirituality support group, she discovered relief and empowerment.

 #cancercare #breastcancer #support #shareherjourney #empowerment #testimonial
CancerCare (@cancercare) 's Twitter Profile Photo

The Senate HELP Committee GOP HELP Committee Dems hearing today focuses on how the #340B program affects low-income patients. We applaud the Senate HELP Committee’s efforts to improve the program to protect patients. Watch the hearing live here: help.senate.gov/hearings/the-3…

Multiple Myeloma RF (@themmrf) 's Twitter Profile Photo

U.S. FDA has approved Blenrep (belantamab mafodotin) to treat relapsed/refractory #myeloma patients who have received two prior lines of therapy. Read more: ow.ly/jiey50XhbMz

<a href="/US_FDA/">U.S. FDA</a> has approved Blenrep (belantamab mafodotin) to treat relapsed/refractory #myeloma patients who have received two prior lines of therapy. Read more: ow.ly/jiey50XhbMz
CancerCare (@cancercare) 's Twitter Profile Photo

This #HealthLiteracyMonth, CancerCare would like to highlight our free, easy-to-read and trustworthy publications. Read our publications here: loom.ly/kRhDoyI

This #HealthLiteracyMonth, CancerCare would like to highlight our free, easy-to-read and trustworthy publications. 

Read our publications here: loom.ly/kRhDoyI
FDA Oncology (@fdaoncology) 's Twitter Profile Photo

#FDA approves a treatment for relapsed or refractory acute myeloid leukemia with a susceptible NPM1 mutation. fda.gov/drugs/resource…

#FDA approves a treatment for relapsed or refractory acute myeloid leukemia with a susceptible NPM1 mutation.
fda.gov/drugs/resource…
CancerCare (@cancercare) 's Twitter Profile Photo

CancerCare would like to highlight our free services and resources for people diagnosed with brain cancer and their loved ones, which include support groups, workshops, publications and more. Learn more: cancercare.org/brain_cancer #InternationalBrainTumorAwarenessWeek